Holly J. Meany

Holly J. Meany

Pediatric Hematology Oncology
111 Michigan Avenue Northwest
Washington, DC 20010

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Author Correction: Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Author Correction: Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Journal: Nature medicine
Published: July 22, 2026

Treatment of extracranial rhabdoid tumor with intensive ifosfamide-containing chemotherapy regimens.

Treatment of extracranial rhabdoid tumor with intensive ifosfamide-containing chemotherapy regimens.

Journal: Frontiers in oncology
Published: January 11, 2026

Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Journal: Nature medicine
Published: October 09, 2025

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study.

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study.

Journal: Pediatric blood & cancer
Published: October 03, 2025

Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.

Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.

Journal: Pediatric blood & cancer
Published: March 16, 2021

Epithelioid Sarcoma in a Young Child: A Case Report and Literature Review.

Epithelioid Sarcoma in a Young Child: A Case Report and Literature Review.

Journal: Plastic and reconstructive surgery. Global open
Published: August 10, 2020

Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study.

Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 30, 2019

Non-High-Risk Neuroblastoma: Classification and Achievements in Therapy.

Non-High-Risk Neuroblastoma: Classification and Achievements in Therapy.

Journal: Children (Basel, Switzerland)
Published: December 03, 2018

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 17, 2018

Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function.

Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function.

Journal: Pediatric blood & cancer
Published: July 17, 2018

Treatment of Transient Peripheral Neuropathy During Chimeric 14.18 Antibody Therapy in Children With Neuroblastoma: A Case Series.

Treatment of Transient Peripheral Neuropathy During Chimeric 14.18 Antibody Therapy in Children With Neuroblastoma: A Case Series.

Journal: Journal of pediatric hematology/oncology
Published: July 06, 2017

Voices of children and adolescents on phase 1 or phase 2 cancer trials: A new trial endpoint?

Voices of children and adolescents on phase 1 or phase 2 cancer trials: A new trial endpoint?

Journal: Cancer
Published: December 21, 2016
Showing 1-12 of 25

Last Updated: 09/26/2026